StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
Huagongshe Open Project:[email protected]KI-Anbindung: llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.7.8
  1. Startseite
  2. /Verbindung

Anthranilate

HCID 5459842
NotizenReaktionen
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
9031-59-8
Standard-SMILES
Nc1ccccc1C(=O)[O-]
InChIKey
RWZYAGGXGHYGMB-UHFFFAOYSA-M
Summenformel
C7H6NO2-
Durchschnittliche Molmasse
136,13 g/mol
Monoisotopische Masse
136,03985343

Überblick

Anthranilate is an aminobenzoate that is the conjugate base of anthranilic acid, obtained by deprotonation of the carboxy group. It has a role as a mouse metabolite, a Saccharomyces cerevisiae metabolite and a human metabolite. It is a conjugate base of an anthranilic acid.

Namen und Bezeichner

Bevorzugter Name
Anthranilate
IUPAC
2-aminobenzoate
Englischer Name
Anthranilate Synthase
Molmasse
0

Namen und Synonyme

anthranilateo-AminobenzoateCHEBI:16567RefChem:9159532-aminobenzoateAnthranic acid9031-59-8DTXSID804200803h78RWZYAGGXGHYGMB-UHFFFAOYSA-Mc0345AKOS024456031
Weitere Namen anzeigen
Anthranilate Synthase
Q27101976

Datenbank-Bezeichner

CAS
9031-59-8
PubChem CID
5459842
DTXSID
DTXSID80420080
ChEBI
CHEBI:16567
Nikkaji
J258.951F

Eigenschaften

Berechnete Struktureigenschaften

XLogP
1,9
Polarare Oberfläche (TPSA)
66,2 Ų
H-Brücken-Donoren
1
H-Brücken-Akzeptoren
3
Frei drehbare Bindungen
0
Schwere Atome
10
Formalladung
-1
Komplexität
130

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

Toxikologische Informationen

TreatmentKidney dialysis is usually needed to relieve the symptoms of uremic syndrome until normal kidney function can be restored.
Health EffectsChronic exposure to uremic toxins can lead to a number of conditions including renal damage, chronic kidney disease and cardiovascular disease.
Exposure RoutesEndogenous, Ingestion, Dermal (contact)
Toxicity Summary · 1 Eintrag

Uremic toxins such as anthranilic acid are actively transported into the kidneys via organic ion transporters (especially OAT3). Increased levels of uremic toxins can stimulate the production of reactive oxygen species. This seems to be mediated by the direct binding or inhibition by uremic toxins of the enzyme NADPH oxidase (especially NOX4 which is abundant in the kidneys and heart) (A7868). Reactive oxygen species can induce several different DNA methyltransferases (DNMTs) which are involved in the silencing of a protein known as KLOTHO. KLOTHO has been identified as having important roles in anti-aging, mineral metabolism, and vitamin D metabolism. A number of studies have indicated that KLOTHO mRNA and protein levels are reduced during acute or chronic kidney diseases in response to high local levels of reactive oxygen species (A7869).

Signs and Symptoms · 1 Eintrag

As a uremic toxin, this compound can cause uremic syndrome. Uremic syndrome may affect any part of the body and can cause nausea, vomiting, loss of appetite, and weight loss. It can also cause changes in mental status, such as confusion, reduced awareness, agitation, psychosis, seizures, and coma. Abnormal bleeding, such as bleeding spontaneously or profusely from a very minor injury can also occur. Heart problems, such as an irregular heartbeat, inflammation in the sac that surrounds the heart (pericarditis), and increased pressure on the heart can be seen in patients with uremic syndrome. Shortness of breath from fluid buildup in the space between the lungs and the chest wall (pleural effusion) can also be present.

Chemie und Industrie

Pharmakologische Informationen

Metabolism/MetabolitesUremic toxins tend to accumulate in the blood either through dietary excess or through poor filtration by the kidneys. Most uremic toxins are metabolic waste products and are normally excreted in the urine or feces.
MeSH Pharmacological ClassificationDrugs used to prevent SEIZURES or reduce their severity.

Verwendung und Herstellung

UsesNaturally produced by the body (endogenous).

Anbieter1 Anbieter

Creative Enzymes1-516-855-7709 · [email protected]

Zugehörige Reaktionen

4
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 44432
HRID 44432als Eduktuspto-grants-2013_09
Reaktionsgleichung von HRID 583838
HRID 583838als Eduktuspto-grants-2005_08
Reaktionsgleichung von HRID 1534858
HRID 1534858als Eduktuspto-grants-1992_02
Reaktionsgleichung von HRID 2331661
HRID 2331661als ProduktTraining data from https://doi.org/10.1039/C8SC04228D (10/10)

Notizen zur Verbindung

Wird geladen…

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
Carcinogen Classification3, not classifiable as to its carcinogenicity to humans. (L135)